Test Code LAB2123 Toxoplasma gondii, Molecular Detection, PCR, Varies
Useful For
Supporting the diagnosis of acute cerebral, ocular, disseminated, or congenital toxoplasmosis
This test should not be used to screen healthy patients.
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
VariesNecessary Information
Specimen source is required.
Specimen Required
Submit only 1 of the following specimens:
Specimen Type: Amniotic fluid
Container/Tube: Sterile container
Specimen Volume: 0.5 mL
Collection Instructions: Do not centrifuge.
Specimen Type: Spinal fluid
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Container/Tube:
Preferred: 12 x 75-mm screw cap vial
Acceptable: Sterile vial
Specimen Volume: 0.5 mL
Collection Instructions: Do not centrifuge.
Specimen Type: Fresh tissue
Supplies:M4-RT (T605)
Container/Tube:
Preferred: Multi-microbe medium (eg, M4-RT)
Acceptable: Sterile container with 1 to 2 mL of sterile saline
Specimen Volume: Entire collection
Collection Instructions: Submit only fresh tissue in a sterile container containing 1 mL to 2 mL of sterile saline or multi-microbe medium (M4-RT, M4, or M5)
Specimen Type: Ocular fluid
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container: 12 x 75-mm screw cap vial
Specimen Volume: 0.3 mL
Collection Instructions:
1. Aliquot collected fluid into screw-cap vial. Do not submit ocular fluid in syringe.
2. Do not centrifuge or dilute the specimen.
Specimen Minimum Volume
Amniotic Fluid, Ocular Fluid, Spinal Fluid: 0.3 mL
Tissue: 2 × 2 mm biopsy
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Refrigerated (preferred) | 7 days | |
Frozen | 7 days |
Reference Values
Negative
Day(s) Performed
Monday through Saturday
CPT Code Information
87798
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PTOX | Toxoplasma gondii PCR | 29904-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
SRC74 | Specimen Source | 31208-2 |
81795 | Toxoplasma gondii PCR | 29904-0 |
Interpretation
A positive result indicates presence of DNA from Toxoplasma gondii.
Negative results indicate absence of detectable DNA but do not exclude the presence of organism or active or recent disease.
Method Description
DNA from clinical specimens is extracted using the Roche MagNA Pure system. Toxoplasma gondii DNA is then detected by using real-time polymerase chain reaction (PCR) to amplify the target sequence. The LightCycler amplifies and monitors fluorescent development of target nucleic acid after each cycle. The continuous monitoring is derived from the fluorescence resonance energy transfer (FRET) principle: a hybridization probe with a donor fluorophore on the 3' end is excited by an external light source and emits light that is absorbed by a second hybridization probe with an acceptor fluorophore at the 5' end. The acceptor fluorophore emits light of a different wavelength that can be measured with a signal that is proportional to the amount of specific PCR product. Melting temperature analysis is used following amplification for sensitive and specific detection of amplified target DNA.(Cockerill FR, Uhl FR. Applications and challenges of real-time PCR for the clinical microbiology laboratory. In: Reischl U, Wittwer C, Cockerill F, eds. Rapid Cycle Real-Time PCR, 2002; Nolte FS. Target amplification techniques. In Carroll KC, Pfaller MA, Landry ML, et al, eds. Manual of Clinical Microbiology. 12th ed. ASM Press; 2019)
Report Available
Same day/1 to 4 daysSpecimen Retention Time
7 daysReject Due To
Heat-inactivated specimen | Reject |
Method Name
Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.
Testing Algorithm
For more information see Meningitis/Encephalitis Panel Algorithm